Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Hester Biosciences Ltd Major Shareholding Notification 2020

Apr 3, 2020

62222_rns_2020-04-03_605f94cc-d835-4997-b6ca-9f0adabd1070.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

From RAJIV GANDHI B-3, 399 Apartment, Bodakdev, Ahmedabad 380 054

Date: 3 April 2020

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001

To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 Symbol: HESTERBIO

Scrip Code: 524669 Dear Sir / Madam:

Subject: Disclosure under Regulations 30 (1) & 30 (2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Pursuant to Regulation 30(1) & 30 (2) of the SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011, on behalf of the promoters of the Hester Biosciences Limited as defined in Regulation 2 (i) (s) of the said Regulations and hereby inform that as on 31 March 2020, my holding together with other promoters and promoters group was 45,70,944 Equity Shares of the Hester Biosciences Limited i.e. 53.73% of the total Paid-up Equity Capital.

Kindly find enclosed Disclosure under Regulations 30(1) & 30(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, in the prescribed format as in annexure.

Sincerely,

(Rajiv Gandhi)

Enclosure: As above

CC TO:

To The Company Secretary & Compliance Officer Hester Biosciences Limited 1st Floor, Pushpak, Panchavati Circle, Motilal Hirabhai Road, Ahmedabad – 380 006

Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Part-A- Details of Shareholding:

1.Name of the Target Company (TC) HESTER BIOSCIENCES LIMITED
2.Name(s) of the Stock Exchange(s) wherethe shares of the TC are listed BSE Limited;National Stock Exchange of IndiaLimited
3.Particulars of the shareholder(s):a.Nameofperson(s)togetherwithPersonsActinginConcert(PAC)whose total holding (including that intheformofshares,warrants,convertible securities and any otherinstrument that would entitletheholder to receive shares in the targetcompany) is more than 25% of thevoting rights of the TC.Orb.Name(s) of promoter(s), member ofthepromotergroupandPersonsActing in Concert (PAC) with him. Not ApplicableAs per Annexure - 1(attached herewith)
4.ParticularsoftheShareholdingofpersons mentioned at (3) above Number ofShares % w. r. t.totalshare /votingcapitalwhereverapplicable % of totaldilutedshare/votingcapital ofTC (*)
As of 31 March 2020 , holding of:
a.Sharesb.VotingRights(otherwisethanbyshares)c.Warrants,d.Convertible Securitiese.Anyotherinstrumentthatwouldentitle the holder to receive shares inthe TC. 45,70,944---- 53.73---- 53.73----
Total 45,70,944 53.73 53.73

_______________

(Rajiv Gandhi)

Place: Ahmedabad Date: 3 April 2020

Part-B**

Name of the Target Company: HESTER BIOSCIENCES LIMITED

Name(s) of the acquirer andPersons Acting in Concert (PAC)with the acquirer Whether theacquirer belongsto Promoter/Promoter group
Mr. Rajiv Dinesh Gandhi Yes
Ms. Nina Rajiv Gandhi Yes
Mr. Sanjiv Dinesh Gandhi Yes
Mr. Ravin Gandhi Yes
Ms. Bela Gandhi Yes
Dr. Bhupendra Vittaldas Gandhi Yes
Bhupendra Vittaldas Gandhi HUF Yes
Ms. Madhuri Kapadia Yes
Ms. Shaila Bhupendra Gandhi Yes
Mr. Anup Chandravadan Kapadia Yes
Ms. Hetal Sanjiv Gandhi Yes
Mr. Yash Rajiv Gandhi Yes
Biolink Healthcare Limited Yes
Hester Diagnostics Private Limited Yes
Hester Coatings LLP Yes

___________

(Rajiv Gandhi)

Place: Ahmedabad Date: 3 April 2020

Note:

  1. In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.

(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

(**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.

ANNEXURE - 1

Name of Promoters No. of Shares held % of holding
Mr. Rajiv Dinesh Gandhi 8,85,397 10.41
Ms. Nina Rajiv Gandhi 6,96,340 8.19
Mr. Sanjiv Dinesh Gandhi 6,92,820 8.14
Mr. Ravin Gandhi 4,03,320 4.74
Ms. Bela Gandhi 4,00,635 4.71
Dr. Bhupendra Vithaldas Gandhi 3,99,100 4.69
Bhupendra Vithaldas Gandhi HUF 3,11,600 3.66
Biolink Healthcare Limited 2,48,838 2.93
Ms. Madhuri Kapadia 2,01,354 2.37
Ms. Shaila Bhupendra Gandhi 1,89,700 2.23
Hester Coatings LLP 64,000 0.75
Mr. Anup Chandravadan Kapadia 27,000 0.32
Hester Diagnostics Private Limited 24,000 0.28
Ms. Hetal Sanjiv Gandhi 19,590 0.23
Mr. Yash Rajiv Gandhi 7,250 0.08
Total 45,70,944 53.73

SHAREHOLDING OF PROMOTERS AND PROMOTERS GROUP AS ON 31 MARCH 2020

___________

(Rajiv Gandhi)

Place: Ahmedabad Date: 3 April 2020